
Please try another search
(Reuters) - Canada's BlackBerry Ltd (TO:BB) (N:BB) posted a surprise 6% rise in quarterly revenue on Thursday, as sales of its security software product rose and its patent licensing business strengthened.
U.S.-listed shares of BlackBerry, which sells security software to companies and governments as well as infotainment software to carmakers, rose 6% in early morning trade.
BlackBerry's QNX car software sales, which had been under pressure due to a pandemic-related weakness in the U.S. auto industry, also improved in the quarter. Demand for new vehicles has been recovering after hitting a bottom in April, as lockdown restrictions ease and buyers return.
"Some signs of recovery in auto production point to sequential revenue growth and a return to a normal run rate for QNX by early next year," Chief Executive John Chen said in a statement.
The quarter benefited from higher sales of the company's core security software, Spark, as businesses continue to strengthen their IT security to support remote working trends.
In a post-earnings call with analysts, the company said its patent licensing business also performed strongly, contributing $108 million to total revenue.
Morningstar analyst Mark Cash said BlackBerry Spark provides the company with future demand as enterprises and government entities work to protect and manage devices.
The company reiterated it full year revenue forecast of about $950 million. Analysts expect revenue to be $956 million.
Total revenue for the second quarter ended Aug. 31 was $259 million, while analysts were expecting it to drop to $237.03 million from $244 million a year earlier, according IBES data from Refinitiv.
Excluding items, the company reported a profit 11 cents per share, compared with analysts' estimates of 2 cents per share.
Net loss narrowed to $23 million, or 4 cents per share, from $44 million, or 10 cents per share, a year earlier.
By Richa Naidu LONDON (Reuters) - Danone SA (OTC:DANOY) on Wednesday said it has been doubling shipments to the United States of Neocate formula for infants allergic to cow's...
By Michael Erman (Reuters) - Pfizer Inc (NYSE:PFE) will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance...
LONDON (Reuters) -British retailer Marks & Spencer (OTC:MAKSY) joined rivals in warning on the outlook for the current year amid a worsening cost-of-living crunch, taking the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.